Skip to content
Buy State Bank of India; target of Rs 915: Sharekhan

Buy State Bank of India; target of Rs 915: Sharekhan

Sharekhan is bullish on State Bank of India has recommended buy rating on the stock with a target price of Rs 915 in its research report dated February 29, 2024.

Read More

​ Sharekhan is bullish on State Bank of India has recommended buy rating on the stock with a target price of Rs 915 in its research report dated February 29, 2024. Sharekhan is bullish on State Bank of India has recommended buy rating on the stock with a target price of Rs 915 in its research report dated February 29, 2024.  Moneycontrol Latest News Read More  

Sharekhan is bullish on State Bank of India has recommended buy rating on the stock with a target price of Rs 915 in its research report dated February 29, 2024.

What does rollover data say about position build-up in the March series

What does rollover data say about position build-up in the March series

The Rollover for the Nifty Index futures stood at 79.31 percent, a decline from the previous month#39;s 81.28 percent and the three-month average of 80.04 percent

Read More

​ The Rollover for the Nifty Index futures stood at 79.31 percent, a decline from the previous month#39;s 81.28 percent and the three-month average of 80.04 percent The Rollover for the Nifty Index futures stood at 79.31 percent, a decline from the previous month#39;s 81.28 percent and the three-month average of 80.04 percent  Moneycontrol Latest News Read More  

The Rollover for the Nifty Index futures stood at 79.31 percent, a decline from the previous month#39;s 81.28 percent and the three-month average of 80.04 percent

Sell Suven Pharmaceuticals; target of Rs 571: Geojit

Sell Suven Pharmaceuticals; target of Rs 571: Geojit

Geojit is bearish on Suven Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 571 in its research report dated February 29, 2024.

Read More

​ Geojit is bearish on Suven Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 571 in its research report dated February 29, 2024. Geojit is bearish on Suven Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 571 in its research report dated February 29, 2024.  Moneycontrol Latest News Read More  

Geojit is bearish on Suven Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 571 in its research report dated February 29, 2024.

Nifty hits all-time high, Sensex zooms 1,000 points; 5 factors fuelling the rally

Nifty hits all-time high, Sensex zooms 1,000 points; 5 factors fuelling the rally

Positive global cues also helped indices move higher as Wall Street stock closed in the green overnight and Asian markets were also trading higher.

Read More

​ Positive global cues also helped indices move higher as Wall Street stock closed in the green overnight and Asian markets were also trading higher. Positive global cues also helped indices move higher as Wall Street stock closed in the green overnight and Asian markets were also trading higher.  Moneycontrol Latest News Read More  

Positive global cues also helped indices move higher as Wall Street stock closed in the green overnight and Asian markets were also trading higher.

India is crucial for Nokia’s foray in 6G technology development and services, says top official

India is crucial for Nokia’s foray in 6G technology development and services, says top official

Nokia is also exploring investment opportunities in Indian startups, particularly those operating in digital industries, cybersecurity, and network decentralisation.

Read More

​ Nokia is also exploring investment opportunities in Indian startups, particularly those operating in digital industries, cybersecurity, and network decentralisation. Nokia is also exploring investment opportunities in Indian startups, particularly those operating in digital industries, cybersecurity, and network decentralisation.  Moneycontrol Latest News Read More  

Nokia is also exploring investment opportunities in Indian startups, particularly those operating in digital industries, cybersecurity, and network decentralisation.

Buy Godrej Consumer; target of Rs 1500: Motilal Oswal

Buy Godrej Consumer; target of Rs 1500: Motilal Oswal

Motilal Oswal is bullish on Godrej Consumer recommended buy rating on the stock with a target price of Rs 1500 in its research report dated February 29, 2024.

Read More

​ Motilal Oswal is bullish on Godrej Consumer recommended buy rating on the stock with a target price of Rs 1500 in its research report dated February 29, 2024. Motilal Oswal is bullish on Godrej Consumer recommended buy rating on the stock with a target price of Rs 1500 in its research report dated February 29, 2024.  Moneycontrol Latest News Read More  

Motilal Oswal is bullish on Godrej Consumer recommended buy rating on the stock with a target price of Rs 1500 in its research report dated February 29, 2024.

Suven Pharma zooms 12% on merger with Cohance Lifesciences

Suven Pharma zooms 12% on merger with Cohance Lifesciences

Suven Pharmaceuticals Limited on February 29 announced a scheme of amalgamation for merger with Cohance Lifesciences Limited

Read More

​ Suven Pharmaceuticals Limited on February 29 announced a scheme of amalgamation for merger with Cohance Lifesciences Limited Suven Pharmaceuticals Limited on February 29 announced a scheme of amalgamation for merger with Cohance Lifesciences Limited  Moneycontrol Latest News Read More  

Suven Pharmaceuticals Limited on February 29 announced a scheme of amalgamation for merger with Cohance Lifesciences Limited

Accumulate Astral; target of Rs 2627: Asit C Mehta

Accumulate Astral; target of Rs 2627: Asit C Mehta

Asit C Mehta recommended Accumulate rating on Astral with a target price of Rs 2627 in its research report dated February 23 2024.

Read More

​ Asit C Mehta recommended Accumulate rating on Astral with a target price of Rs 2627 in its research report dated February 23 2024. Asit C Mehta recommended Accumulate rating on Astral with a target price of Rs 2627 in its research report dated February 23 2024.  Moneycontrol Latest News Read More  

Asit C Mehta recommended Accumulate rating on Astral with a target price of Rs 2627 in its research report dated February 23 2024.

India#39;s February manufacturing PMI rises to 56.9, highest in 5 months

India#39;s February manufacturing PMI rises to 56.9, highest in 5 months

The February flash Purchasing Managers#39; Index for the Indian manufacturing sector, released on February 22, had come in at 56.7.

Read More

​ The February flash Purchasing Managers#39; Index for the Indian manufacturing sector, released on February 22, had come in at 56.7. The February flash Purchasing Managers#39; Index for the Indian manufacturing sector, released on February 22, had come in at 56.7.  Moneycontrol Latest News Read More  

The February flash Purchasing Managers#39; Index for the Indian manufacturing sector, released on February 22, had come in at 56.7.

en_USEnglish